Literature DB >> 9389850

Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.

P Mezin1, J F Payen, J L Bosson, E Brambilla, P Stieglitz.   

Abstract

The aim of this study was to find, using modern techniques, any histological differences in muscle biopsies between malignant hyperthermia (MH) susceptible (MHS), MH equivocal (MHE) and MH negative (MHN) patients. On the basis of the European MH contracture test carried out in 83 patients, 23 were shown to be MHS, nine MHE and 51 MHN. Four lesions were found with a significantly high frequency in MHS and MHE biopsies: muscle fibre hypertrophy and atrophy, internal nuclei and myofibrillar necrosis. These four lesions were observed together in 35% of MHS but in none of the MHE or MHN biopsies. Three of these lesions occurred together in 57% of MHS, 33% of MHE and 4% of MHN biopsies. Our results support a histological difference between MHE, MHS and MHN biopsies and attempt to contribute towards a better definition of MHE status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389850     DOI: 10.1093/bja/79.3.327

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.

Authors:  Cecilia Giulivi; Catherine Ross-Inta; Alicja Omanska-Klusek; Eleonora Napoli; Danielle Sakaguchi; Genaro Barrientos; Paul D Allen; Isaac N Pessah
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Oxidative capacity and fatigability in run-trained malignant hyperthermia-susceptible mice.

Authors:  Clement Rouviere; Benjamin T Corona; Christopher P Ingalls
Journal:  Muscle Nerve       Date:  2012-04       Impact factor: 3.217

Review 3.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

Review 4.  [Malignant hyperthermia].

Authors:  Fritz Zimprich; Hans Georg Kress; Josef Zeitlhofer
Journal:  Wien Klin Wochenschr       Date:  2003-09-15       Impact factor: 1.704

5.  Sudden death due to malignant hyperthermia with a mutation of RYR1: autopsy, morphology and genetic analysis.

Authors:  Wenhe Li; Lin Zhang; Yue Liang; Fang Tong; Yiwu Zhou
Journal:  Forensic Sci Med Pathol       Date:  2017-11-04       Impact factor: 2.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.